MA29935B1 - Inhibiteurs de l'activite de akt - Google Patents
Inhibiteurs de l'activite de aktInfo
- Publication number
- MA29935B1 MA29935B1 MA30904A MA30904A MA29935B1 MA 29935 B1 MA29935 B1 MA 29935B1 MA 30904 A MA30904 A MA 30904A MA 30904 A MA30904 A MA 30904A MA 29935 B1 MA29935 B1 MA 29935B1
- Authority
- MA
- Morocco
- Prior art keywords
- inhibitors
- akt activity
- activity
- compounds
- imidazo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
L'INVENTION CONCERNE DE NOUVEAUX COMPOSÉS 1 H-IMIDAZO[4,5-C];PYRIDIN-2-YL, L'UTILISATION DE CES COMPOSÉS EN TANT QU'INHIBITEURS DE L'ACTIVITÉ DE LA PROTÉINE KINASE B, ET POUR LE TRAITEMENT DU CANCER ET DE L'ARTHRITE.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73595505P | 2005-11-10 | 2005-11-10 | |
US77228906P | 2006-02-10 | 2006-02-10 | |
US82692806P | 2006-09-26 | 2006-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29935B1 true MA29935B1 (fr) | 2008-11-03 |
Family
ID=38049129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA30904A MA29935B1 (fr) | 2005-11-10 | 2008-05-05 | Inhibiteurs de l'activite de akt |
Country Status (16)
Country | Link |
---|---|
US (1) | US20100056523A1 (fr) |
EP (1) | EP1948188A4 (fr) |
JP (1) | JP2009516653A (fr) |
KR (1) | KR20080067646A (fr) |
AP (1) | AP2008004442A0 (fr) |
AR (1) | AR056786A1 (fr) |
AU (1) | AU2006315805A1 (fr) |
BR (1) | BRPI0618309A2 (fr) |
CA (1) | CA2629429A1 (fr) |
EA (1) | EA200801301A1 (fr) |
EC (1) | ECSP088425A (fr) |
IL (1) | IL190968A0 (fr) |
MA (1) | MA29935B1 (fr) |
NO (1) | NO20082414L (fr) |
TW (1) | TW200736260A (fr) |
WO (1) | WO2007058850A2 (fr) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1948185A4 (fr) * | 2005-11-10 | 2010-04-21 | Glaxosmithkline Llc | Inhibiteurs de l'activite de l'akt |
AU2009205956B2 (en) | 2008-01-18 | 2015-07-02 | President And Fellows Of Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
ATE547707T1 (de) * | 2008-05-16 | 2012-03-15 | Cellzome Ag | Verfahren zur identifizierung von mit parp wechselwirkenden molekülen und zur aufreinigung von parp-proteinen |
US20110086834A1 (en) * | 2008-06-26 | 2011-04-14 | Amgen Inc. | Alkynyl alcohols as kinase inhibitors |
RU2011123647A (ru) | 2008-11-10 | 2012-12-20 | Вертекс Фармасьютикалз Инкорпорейтед | Соединения, полезные в качестве ингибиторов atr киназы |
SG172248A1 (en) | 2008-12-19 | 2011-07-28 | Vertex Pharma | Pyrazine derivatives useful as inhibitors of atr kinase |
CA2798763A1 (fr) | 2010-05-12 | 2011-11-17 | Vertex Pharmaceuticals Incorporated | Composes utiles comme inhibiteurs de la kinase atr |
WO2011143399A1 (fr) | 2010-05-12 | 2011-11-17 | Vertex Pharmaceuticals Incorporated | Composés utiles en tant qu'inhibiteurs de l'atr kinase |
EP2569287B1 (fr) | 2010-05-12 | 2014-07-09 | Vertex Pharmaceuticals Inc. | Composés utilisables en tant qu'inhibiteurs de la kinase atr |
WO2011143419A1 (fr) | 2010-05-12 | 2011-11-17 | Vertex Pharmaceuticals Incorporated | Pyrazines utiles en tant qu'inhibiteurs de la kinase atr |
US9062008B2 (en) | 2010-05-12 | 2015-06-23 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
EP2569284B1 (fr) | 2010-05-12 | 2015-07-08 | Vertex Pharmaceuticals Incorporated | Dérivés de 2-aminopyridine utiles en tant qu'inhibiteurs de la kinase atr |
NZ605627A (en) | 2010-06-23 | 2015-06-26 | Vertex Pharma | Pyrrolo-pyrazine derivatives useful as inhibitors of atr kinase |
EP2596353A4 (fr) | 2010-07-23 | 2014-01-15 | Harvard College | Méthodes de dépistage de maladies ou d'affections prénatales ou liées à la grossesse |
AU2011280997A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
SG10201505724SA (en) * | 2010-07-23 | 2015-09-29 | Harvard College | Methods of detecting diseases or conditions using phagocytic cells |
WO2012123522A1 (fr) | 2011-03-16 | 2012-09-20 | F. Hoffmann-La Roche Ag | Composés d'alcool propargylique 6,5-hétérocycliques et utilisations de ceux-ci |
WO2012138938A1 (fr) | 2011-04-05 | 2012-10-11 | Vertex Pharmaceuticals Incorporated | Composés aminopyrazines utiles en tant qu'inhibiteurs de la kinase atr |
WO2012178125A1 (fr) | 2011-06-22 | 2012-12-27 | Vertex Pharmaceuticals Incorporated | Composés inhibiteurs de la kinase atr |
EP2723747A1 (fr) | 2011-06-22 | 2014-04-30 | Vertex Pharmaceuticals Inc. | Composés utiles comme inhibiteurs de la kinase atr |
WO2012178123A1 (fr) | 2011-06-22 | 2012-12-27 | Vertex Pharmaceuticals Incorporated | Composés utiles comme inhibiteurs de la kinase atr |
US8765751B2 (en) | 2011-09-30 | 2014-07-01 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
US8846686B2 (en) | 2011-09-30 | 2014-09-30 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
EP3878851A1 (fr) | 2011-09-30 | 2021-09-15 | Vertex Pharmaceuticals Incorporated | Procédé de préparation de composés utiles en tant qu'inhibiteurs de kinase d'atr |
CN103957917A (zh) | 2011-09-30 | 2014-07-30 | 沃泰克斯药物股份有限公司 | 用atr抑制剂治疗胰腺癌和非小细胞肺癌 |
US8853217B2 (en) | 2011-09-30 | 2014-10-07 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
EP2776419B1 (fr) | 2011-11-09 | 2016-05-11 | Vertex Pharmaceuticals Incorporated | Composés pyraziniques utiles en tant qu'inhibiteurs de l'atr kinase |
US8841337B2 (en) | 2011-11-09 | 2014-09-23 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
US8846917B2 (en) | 2011-11-09 | 2014-09-30 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
WO2013071094A1 (fr) | 2011-11-09 | 2013-05-16 | Vertex Pharmaceuticals Incorporated | Composés utiles comme inhibiteurs de kinase atr |
EP2776420A1 (fr) | 2011-11-09 | 2014-09-17 | Vertex Pharmaceuticals Incorporated | Composés de pyrazine utiles comme inhibiteurs de kinase atr |
PL2833973T3 (pl) | 2012-04-05 | 2018-02-28 | Vertex Pharmaceuticals Incorporated | Związki użyteczne jako inhibitory kinazy ATR i ich terapie skojarzone |
EP2904406B1 (fr) | 2012-10-04 | 2018-03-21 | Vertex Pharmaceuticals Incorporated | Procédée pour la détermination de dommage de adn augmenté par inhibition de atr |
WO2014062604A1 (fr) | 2012-10-16 | 2014-04-24 | Vertex Pharmaceuticals Incorporated | Composés utiles en tant qu'inhibiteurs de la kinase atr |
BR112015012454B1 (pt) | 2012-12-07 | 2022-07-05 | Vertex Pharmaceuticals Incorporated | Compostos inibidores de atr quinase, seu uso e composição farmacêutica compreendendo os mesmos |
US10494675B2 (en) | 2013-03-09 | 2019-12-03 | Cell Mdx, Llc | Methods of detecting cancer |
US9663519B2 (en) | 2013-03-15 | 2017-05-30 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
TWI663166B (zh) | 2013-04-24 | 2019-06-21 | 健生藥品公司 | 新化合物 |
EP3013818B1 (fr) * | 2013-06-26 | 2021-12-29 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | (s)-énantiomère de mepazine en tant qu'inhibiteur de paracaspase (malt1) pour le traitement du cancer |
AU2014293011A1 (en) | 2013-07-26 | 2016-03-17 | Race Oncology Ltd. | Compositions to improve the therapeutic benefit of bisantrene |
TWI627173B (zh) | 2013-09-26 | 2018-06-21 | 比利時商健生藥品公司 | 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物 |
TWI704146B (zh) * | 2013-09-26 | 2020-09-11 | 比利時商健生藥品公司 | 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物 |
SG11201604519PA (en) | 2013-12-06 | 2016-07-28 | Vertex Pharma | 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof |
EP3152212B9 (fr) | 2014-06-05 | 2020-05-27 | Vertex Pharmaceuticals Inc. | Dérivés radiomarqués d'un composé 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]-pyrazolo[1,5-a]pyrimidine-3-carboxamide utile comme inhibiteur de la kinase atr, préparation dudit composé, et différentes formes solides associées |
WO2015195740A1 (fr) | 2014-06-17 | 2015-12-23 | Vertex Pharmaceuticals Incorporated | Méthode de traitement anticancéreux utilisant une association d'inhibiteurs de chk1 et d'atr |
US10323045B2 (en) | 2014-10-23 | 2019-06-18 | Janssen Pharmaceutica Nv | Thienopyrimidine derivatives as NIK inhibitors |
MX371150B (es) | 2014-10-23 | 2020-01-20 | Janssen Pharmaceutica Nv | NUEVOS DERIVADOS DE PIRAZOL EN CALIDAD DE INHIBIDORES DE LA CINASA INDUCTORA DE NF-kB (NIK). |
KR102500071B1 (ko) | 2014-10-23 | 2023-02-14 | 얀센 파마슈티카 엔.브이. | Nik 억제제로서의 신규 화합물 |
KR102523405B1 (ko) | 2014-10-23 | 2023-04-18 | 얀센 파마슈티카 엔.브이. | Nik 억제제로서의 신규 피라졸로피리미딘 유도체 |
US11464774B2 (en) | 2015-09-30 | 2022-10-11 | Vertex Pharmaceuticals Incorporated | Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors |
WO2020078865A1 (fr) | 2018-10-16 | 2020-04-23 | F. Hoffmann-La Roche Ag | Utilisation d'inhibiteurs d'akt en ophtalmologie |
KR102650496B1 (ko) | 2018-10-31 | 2024-03-26 | 길리애드 사이언시즈, 인코포레이티드 | Hpk1 억제제로서의 치환된 6-아자벤즈이미다졸 화합물 |
CN117105933A (zh) | 2018-10-31 | 2023-11-24 | 吉利德科学公司 | 具有hpk1抑制活性的取代的6-氮杂苯并咪唑化合物 |
WO2020237025A1 (fr) | 2019-05-23 | 2020-11-26 | Gilead Sciences, Inc. | Exo-méthylène-oxindoles substitués qui sont des inhibiteurs de hpk1/map4k1 |
WO2023187037A1 (fr) | 2022-03-31 | 2023-10-05 | Astrazeneca Ab | Inhibiteurs de tyrosine kinase du récepteur du facteur de croissance épidermique (egfr) en combinaison avec un inhibiteur d'akt pour le traitement du cancer |
WO2024083716A1 (fr) | 2022-10-17 | 2024-04-25 | Astrazeneca Ab | Combinaisons d'un serd pour le traitement du cancer |
WO2024100236A1 (fr) | 2022-11-11 | 2024-05-16 | Astrazeneca Ab | Polythérapies pour le traitement du cancer |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200523262A (en) * | 2003-07-29 | 2005-07-16 | Smithkline Beecham Corp | Inhibitors of AKT activity |
-
2006
- 2006-11-08 AR ARP060104898A patent/AR056786A1/es unknown
- 2006-11-08 TW TW095141228A patent/TW200736260A/zh unknown
- 2006-11-09 EP EP06837170A patent/EP1948188A4/fr not_active Withdrawn
- 2006-11-09 AU AU2006315805A patent/AU2006315805A1/en not_active Abandoned
- 2006-11-09 JP JP2008540168A patent/JP2009516653A/ja active Pending
- 2006-11-09 US US12/093,032 patent/US20100056523A1/en not_active Abandoned
- 2006-11-09 CA CA002629429A patent/CA2629429A1/fr not_active Abandoned
- 2006-11-09 EA EA200801301A patent/EA200801301A1/ru unknown
- 2006-11-09 BR BRPI0618309-3A patent/BRPI0618309A2/pt not_active Application Discontinuation
- 2006-11-09 WO PCT/US2006/043513 patent/WO2007058850A2/fr active Application Filing
- 2006-11-09 AP AP2008004442A patent/AP2008004442A0/xx unknown
- 2006-11-09 KR KR1020087011158A patent/KR20080067646A/ko not_active Application Discontinuation
-
2008
- 2008-04-17 IL IL190968A patent/IL190968A0/en unknown
- 2008-05-05 MA MA30904A patent/MA29935B1/fr unknown
- 2008-05-05 EC EC2008008425A patent/ECSP088425A/es unknown
- 2008-05-28 NO NO20082414A patent/NO20082414L/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP1948188A2 (fr) | 2008-07-30 |
ECSP088425A (es) | 2008-06-30 |
WO2007058850A2 (fr) | 2007-05-24 |
US20100056523A1 (en) | 2010-03-04 |
KR20080067646A (ko) | 2008-07-21 |
EP1948188A4 (fr) | 2011-02-16 |
CA2629429A1 (fr) | 2007-05-24 |
JP2009516653A (ja) | 2009-04-23 |
TW200736260A (en) | 2007-10-01 |
AR056786A1 (es) | 2007-10-24 |
EA200801301A1 (ru) | 2009-02-27 |
WO2007058850A3 (fr) | 2009-04-30 |
AU2006315805A1 (en) | 2007-05-24 |
AP2008004442A0 (en) | 2008-04-30 |
IL190968A0 (en) | 2009-02-11 |
BRPI0618309A2 (pt) | 2011-08-23 |
NO20082414L (no) | 2008-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29935B1 (fr) | Inhibiteurs de l'activite de akt | |
MA27933A1 (fr) | Inhibiteurs de l'activite de akt | |
MA31167B1 (fr) | Inhibiteurs de l'activite de akt | |
NO20082476L (no) | Bicykliske forbindelser med kinaseinhiberende aktivitet | |
NO20076651L (no) | Fremgangsmate for fremstilling av 2-metyl-l-(2-metylpropyl)-1H-imidazo[4,5-c] [1,5]naftyridin-4-amin | |
NO20091618L (no) | Bicykliske triazoler som proteinkinasemodulatorer | |
ATE301653T1 (de) | Pyrazolopyridine | |
MA28567B1 (fr) | Utilisation de beta-carbolines pour le traitement de maladies inflammatoires | |
DE60214703D1 (de) | Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen | |
ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
TW200716110A (en) | Inhibitors of AKT activity | |
EA201890903A1 (ru) | Соединения пиридиловых ингибиторов передачи сигналов белком hedgehog, способ их получения, композиция и способы лечения рака и ингибирований ангиогенеза и сигнального пути hedgehog в клетках на их основе | |
DE60108754D1 (de) | Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum | |
ATE384061T1 (de) | Imidazo- und thiazolopyridine als jak3-kinase- inhibitoren | |
TW200635591A (en) | 1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate | |
RS51123B (sr) | Aril fuzionisana azapoliciklična jedinjenja | |
BR112013008140A2 (pt) | "compostos imidazotriazinona". | |
ATE532789T1 (de) | Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren | |
ATE493418T1 (de) | Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren | |
ATE472998T1 (de) | Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis | |
WO2007058852A3 (fr) | Inhibiteurs de l’activite de l’akt | |
DE60222465D1 (de) | Pyrazolopyridin-derivate als antiherpesmittel | |
WO2007058879A3 (fr) | Inhibiteurs de l'activité de akt | |
SE0100295D0 (sv) | New compounds | |
NO20042542L (no) | Anvendelse av ascomycin for behandling av blefarit |